Breaking News Instant updates and real-time market news.

2022-07-14 12:25:00 JNJ Johnson & Johnson $175.19 / -0.27 (-0.15%) , ABBV AbbVie $150.00 / -0.85 (-0.56%) … 12:25 07/14/22 07/14 12:25 07/14/22 12:25	Cantor Fitzgerald biotech/pharma analysts hold analyst/industry conference call Biopharma & Biotech Analyst Chen, Biotech Analyst Agrawal and Biopharma Analyst Kim, along with Felix Urman, Asst Professor at Icahn School of Medicine, discuss new and emerging treatments for Atopic Dermatitis and Psoriasis, including JNJ's Tremfya, ABBV's Skyrizi, PFE's Eucrisa, REGN's Dupixent, AMGN's Otezla, INCY's Opzelura and ROIV's Vtama on an Analyst/Industry conference call to be held on July 14 at 1 pm. JNJ Johnson & Johnson $175.19 / -0.27 (-0.15%) ABBV AbbVie $150.00 / -0.85 (-0.56%) PFE Pfizer $51.28 / -0.53 (-1.02%) REGN Regeneron $599.14 / -4.34 (-0.72%) AMGN Amgen $244.67 / -2.48 (-1.00%) INCY Incyte $79.21 / -0.315 (-0.40%) ROIV Roivant Sciences $4.39 / -0.11 (-2.44%)	14 Jul 14 Jul 18 Jul 19 Jul 21 Jul 28 Jul 29 Jul 02 Aug 03 Aug 03 Aug 04 Aug 06 Aug 07 Sep 19 Sep 28 Feb

2022-07-14 12:25:00

JNJ

Johnson & Johnson

$175.19 / -0.27 (-0.15%)

, ABBV

AbbVie

$150.00 / -0.85 (-0.56%)

… 12:25

07/14/22

07/14

12:25

07/14/22

12:25

Cantor Fitzgerald biotech/pharma analysts hold analyst/industry conference call

Biopharma & Biotech Analyst Chen, Biotech Analyst Agrawal and Biopharma Analyst Kim, along with Felix Urman, Asst Professor at Icahn School of Medicine, discuss new and emerging treatments for Atopic Dermatitis and Psoriasis, including JNJ's Tremfya, ABBV's Skyrizi, PFE's Eucrisa, REGN's Dupixent, AMGN's Otezla, INCY's Opzelura and ROIV's Vtama on an Analyst/Industry conference call to be held on July 14 at 1 pm.

JNJ

Johnson & Johnson

$175.19 / -0.27 (-0.15%)

ABBV

AbbVie

$150.00 / -0.85 (-0.56%)

PFE

Pfizer

$51.28 / -0.53 (-1.02%)

REGN

Regeneron

$599.14 / -4.34 (-0.72%)

AMGN

Amgen

$244.67 / -2.48 (-1.00%)

INCY

Incyte

$79.21 / -0.315 (-0.40%)

ROIV

Roivant Sciences

$4.39 / -0.11 (-2.44%)

14
Jul
14
Jul
18
Jul
19
Jul
21
Jul
28
Jul
29
Jul
02
Aug
03
Aug
03
Aug
04
Aug
06
Aug
07
Sep
19
Sep
28
Feb

OTHER BREAKING NEWS FROM THE FLY

Recommendations	Boyd Group Services price target raised to C$215 from C$200 at Scotiabank » 11:26 08/11/22 08/11 11:26 08/11/22 11:26 BYDGF Boyd Group Services $150.11 / +26.94 (+21.87%) Scotiabank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BYDGF Boyd Group Services $150.11 / +26.94 (+21.87%) 07:24 Today National Bank Boyd Group Services downgraded to Sector Perform from Outperform at National Bank 07:02 Today Stifel Boyd Group Services upgraded to Buy from Hold at Stifel 07/25/22 RBC Capital Boyd Group Services assumed with an Outperform at RBC Capital 07/22/22 CIBC Boyd Group Services price target lowered to C$175 from C$180 at CIBC
Recommendations	Argonaut Gold price target lowered to C$1.15 from C$1.25 at Scotiabank » 11:25 08/11/22 08/11 11:25 08/11/22 11:25 ARNGF Argonaut Gold / + Scotiabank analyst Ovais… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research ARNGF Argonaut Gold / + 08/02/22 Stifel Argonaut Gold price target lowered to C$1.50 from C$3.50 at Stifel 07/07/22 Desjardins Argonaut Gold price target lowered to C$1.25 from C$2.50 at Desjardins 07/07/22 BMO Capital Argonaut Gold resumed with an Outperform rating at BMO Capital 07/06/22 Scotiabank Argonaut Gold price target lowered to C$1.25 from C$3.00 at Scotiabank
Recommendations	Andlauer Healthcare price target raised to C$57 from C$54 at Scotiabank » 11:25 08/11/22 08/11 11:25 08/11/22 11:25 ANDHF Andlauer Healthcare $37.80 / + (+0.00%) Scotiabank analyst Konark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ANDHF Andlauer Healthcare $37.80 / + (+0.00%) 07/12/22 National Bank Andlauer Healthcare upgraded to Outperform from Sector Perform at National Bank 05/06/22 RBC Capital Andlauer Healthcare price target lowered to C$48 from C$52 at RBC Capital 05/06/22 National Bank Andlauer Healthcare price target raised to C$50 from C$49.50 at National Bank 05/06/22 TD Securities Andlauer Healthcare price target lowered to C$54 from C$56 at TD Securities
Options	Lemonade call volume above normal and directionally bullish » 11:25 08/11/22 08/11 11:25 08/11/22 11:25 LMND Lemonade $31.14 / +2.5 (+8.73%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options LMND Lemonade $31.14 / +2.5 (+8.73%) 08/08/22 Lemonade jumps 11% to nearly $28 after Q2 report 08/08/22 Lemonade jumps 11% to nearly $28 after Q2 report 08/01/22 Lemonade sells Metromile's Enterprise Business Solutions platform to EIS 05/10/22 Lemonade trading resumes LMND Lemonade $31.14 / +2.5 (+8.73%) 08/10/22 Oppenheimer Lemonade price target raised to $35 from $30 at Oppenheimer 08/10/22 Barclays Lemonade price target raised to $28 from $20 at Barclays 07/18/22 Piper Sandler Lemonade downgraded to Neutral from Overweight at Piper Sandler 05/11/22 Oppenheimer Lemonade price target lowered to $30 from $45 at Oppenheimer LMND Lemonade $31.14 / +2.5 (+8.73%) 08/08/22 Lemonade raises FY22 revenue view to $236M-$239M, consensus $213.41M 08/08/22 Lemonade sees Q3 revenue $63M-$65M, consensus $56.97M 08/08/22 Lemonade reports Q2 EPS ($1.10), consensus ($1.32) 05/09/22 Lemonade sees FY22 revenue $205M-$208M, consensus $216.49M LMND Lemonade $31.14 / +2.5 (+8.73%) 02/14/22 Socially conscious sock maker Bombas exploring IPO, Bloomberg says LMND Lemonade $31.14 / +2.5 (+8.73%) 08/08/22 Fly Intel: After-Hours Movers 08/07/22 Short Report: Bed Bath Beyond in short-squeeze spotlight 06/25/22 Short Report: Bears undeterred by bounce in growth names 02/23/22 Fly Intel: After-Hours Movers LMND Lemonade $31.14 / +2.5 (+8.73%) 08/10/22 Lemonade call volume above normal and directionally bullish 08/08/22 Lemonade options imply 12.1% move in share price post-earnings 07/06/22 Largest borrow rate increases among liquid names 06/14/22 Largest borrow rate increases among liquid names
Recommendations	American Hotel Income Properties price target lowered to C$4.50 at Scotiabank » 11:24 08/11/22 08/11 11:24 08/11/22 11:24 AHOTF American Hotel Income Properties $2.85 / +0.1745 (+6.53%) Scotiabank analyst Mario… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research AHOTF American Hotel Income Properties $2.85 / +0.1745 (+6.53%) 11:20 Today National Bank American Hotel Income Properties price target raised to C$4 at National Bank 05/18/22 National Bank American Hotel Income Properties price target lowered to C$4.75 at National Bank 05/12/22 Scotiabank American Hotel Income price target lowered to C$4.75 from C$5 at Scotiabank 03/10/22 National Bank American Hotel Income Properties price target raised to C$5 at National Bank
Recommendations	ATS Automation price target raised to C$60 from C$55 at Scotiabank » 11:24 08/11/22 08/11 11:24 08/11/22 11:24 ATSAF ATS Automation $35.63 / +2.6651 (+8.08%) Scotiabank analyst Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research ATSAF ATS Automation $35.63 / +2.6651 (+8.08%) 05/20/22 Scotiabank ATS Automation price target raised to C$55 from C$53 at Scotiabank 05/20/22 TD Securities ATS Automation price target raised to C$52 from C$51 at TD Securities 05/20/22 National Bank ATS Automation price target lowered to C$52 from C$66 at National Bank 05/18/22 Scotiabank ATS Automation price target lowered to C$53 from C$63 at Scotiabank
Recommendations	Peyto Exploration price target lowered to C$19 from C$19.50 at National Bank » 11:22 08/11/22 08/11 11:22 08/11/22 11:22 PEYUF Peyto Exploration $10.80 / +0.32 (+3.05%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research PEYUF Peyto Exploration $10.80 / +0.32 (+3.05%) 07/18/22 National Bank Peyto Exploration price target lowered to C$19.50 from C$23 at National Bank 07/14/22 Scotiabank Peyto Exploration price target raised to C$24 from C$23 at Scotiabank 06/30/22 Stifel Peyto Exploration price target lowered to C$19.25 from C$20 at Stifel 06/16/22 National Bank Peyto Exploration price target raised to C$23 from C$18 at National Bank
Recommendations	Goeasy price target raised to C$170 from C$155 at National Bank » 11:22 08/11/22 08/11 11:22 08/11/22 11:22 EHMEF Goeasy $101.67 / +5.36 (+5.57%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research EHMEF Goeasy $101.67 / +5.36 (+5.57%) 07/19/22 Goeasy appoints Jonathan Tetrault to board of directors 07/05/22 Goeasy announces $500M increase to securitization facility EHMEF Goeasy $101.67 / +5.36 (+5.57%) 08/04/22 TD Securities Goeasy price target lowered to C$195 from C$215 at TD Securities 07/20/22 Scotiabank Goeasy price target lowered to C$140 from C$160 at Scotiabank 07/08/22 Raymond James Goeasy price target lowered to C$202 from C$213 at Raymond James 05/13/22 BMO Capital Goeasy price target lowered to C$225 from C$228 at BMO Capital
Recommendations	Dexterra Group price target lowered to C$10.50 from C$12 at National Bank » 11:21 08/11/22 08/11 11:21 08/11/22 11:21 HZNOF Dexterra Group $4.63 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research HZNOF Dexterra Group $4.63 / + (+0.00%) 07/05/22 Raymond James Dexterra Group downgraded to Market Perform from Outperform at Raymond James 05/12/22 Scotiabank Dexterra Group price target lowered to C$10 from C$11 at Scotiabank 05/12/22 Raymond James Dexterra downgraded to Outperform from Strong Buy at Raymond James 05/11/22 TD Securities Dexterra Group price target lowered to C$9 from C$11.50 at TD Securities
Conference/Events	Jefferies consumer goods analyst to hold analyst/industry conference call » 11:20 08/11/22 08/11 11:20 08/11/22 11:20 Retail & Consumer… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial

Recommendations	American Hotel Income Properties price target raised to C$4 at National Bank » 11:20 08/11/22 08/11 11:20 08/11/22 11:20 AHOTF American Hotel Income Properties $2.85 / +0.1745 (+6.53%) National Bank analyst Tal… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research AHOTF American Hotel Income Properties $2.85 / +0.1745 (+6.53%) 05/18/22 National Bank American Hotel Income Properties price target lowered to C$4.75 at National Bank 05/12/22 Scotiabank American Hotel Income price target lowered to C$4.75 from C$5 at Scotiabank 03/10/22 National Bank American Hotel Income Properties price target raised to C$5 at National Bank 11/29/21 BMO Capital American Hotel Income Properties price target raised to C$4.50 at BMO Capital
Recommendations	Dutch Bros price target raised to $45 from $30 at Stifel » 11:17 08/11/22 08/11 11:17 08/11/22 11:17 BROS Dutch Bros $51.52 / +7.46 (+16.93%) Stifel analyst Chris… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options BROS Dutch Bros $51.52 / +7.46 (+16.93%) 09:47 Today Dutch Bros rises 17.9% 06/15/22 Dutch Bros CEO: Demand is not where we would like it to be 05/12/22 Dutch Bros falls -28.4% 05/12/22 Dutch Bros falls -40.1% BROS Dutch Bros $51.52 / +7.46 (+16.93%) 06:31 Today Baird Dutch Bros price target raised to $46 from $30 at Baird 06:14 Today Piper Sandler Dutch Bros price target raised to $50 from $44 at Piper Sandler 07/11/22 Baird Dutch Bros downgraded to Neutral from Outperform at Baird 06/09/22 Barclays Dutch Bros price target raised to $34 from $25 at Barclays BROS Dutch Bros $51.52 / +7.46 (+16.93%) 08/10/22 Dutch Bros backs FY22 revenue view at least $715M, consensus $713.11M 08/10/22 Dutch Bros reports Q2 adjusted EPS 5c, consensus 7c 05/11/22 Dutch Bros sees FY22 revenue $700M-$715M, consensus $717.22M 05/11/22 Dutch Bros reports Q1 adjusted EPS (2c), consensus 1c 11 Mar 15 Sep BROS Dutch Bros $51.52 / +7.46 (+16.93%) 08/10/22 Fly Intel: After-Hours Movers 06/08/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/21/22 Short Report: Bearish bets increase in meme names GameStop and Carvana 05/12/22 What You Missed On Wall Street This Morning BROS Dutch Bros $51.52 / +7.46 (+16.93%) 08/10/22 Dutch Bros options imply 13.3% move in share price post-earnings 08/09/22 Dutch Bros put volume heavy and directionally bearish 07/29/22 Largest borrow rate increases among liquid names 07/11/22 Largest borrow rate increases among liquid names
Technical Analysis	NASDAQ market internals summary » 11:17 08/11/22 08/11 11:17 08/11/22 11:17 $NSD NASDAQ Market Internals / + Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals / + 10:17 Today NASDAQ market internals summary 08/10/22 NASDAQ market internals summary 08/10/22 NASDAQ market internals summary 08/10/22 NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 11:16 08/11/22 08/11 11:16 08/11/22 11:16 $NYE NYSE Market Internals / + Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals / + 10:16 Today NYSE market internals summary 08/10/22 NYSE market internals summary 08/10/22 NYSE market internals summary 08/10/22 NYSE market internals summary
Recommendations	Crew Energy price target raised to C$8 from C$7.75 at Desjardins » 11:16 08/11/22 08/11 11:16 08/11/22 11:16 CWEGF Crew Energy $4.47 / +0.17301 (+4.02%) Desjardins analyst Chris… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research CWEGF Crew Energy $4.47 / +0.17301 (+4.02%) 04/21/22 Crew Energy reports Q1 average production 33,300 boe per day CWEGF Crew Energy $4.47 / +0.17301 (+4.02%) 08/10/22 Stifel Crew Energy price target raised to C$8 from C$7.50 at Stifel 08/10/22 Raymond James Crew Energy price target raised to C$8 from C$7.50 at Raymond James 08/09/22 Scotiabank Crew Energy price target raised to C$8 from C$7.50 at Scotiabank 07/18/22 National Bank Crew Energy price target lowered to C$6.75 from C$7.50 at National Bank
Conference/Events	UBS semiconductor analysts hold an investor relations call series » 11:15 08/11/22 08/11 11:15 08/11/22 11:15 MCHP Microchip $71.68 / +1.05 (+1.49%) Semiconductors Analysts… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MCHP Microchip $71.68 / +1.05 (+1.49%) 08/04/22 Microchip announces SAM9X60DIG-SOM ARM926EJ-S-based embedded MPU 08/02/22 Microchip increased quarterly dividend 9.1% 08/02/22 Microchip announces SMC 2000 series of CXL based Smart Memory Controllers 06/30/22 Microchip announces maXTounch Knob on Display controller MCHP Microchip $71.68 / +1.05 (+1.49%) 08/03/22 B. Riley Microchip price target raised to $86 from $78 at B. Riley 08/03/22 Needham Microchip price target raised to $92 from $75 at Needham 08/03/22 Cowen Microchip price target raised to $72 from $60 at Cowen 08/03/22 JPMorgan Microchip risk/reward attractive at current share levels, says JPMorgan MCHP Microchip $71.68 / +1.05 (+1.49%) 08/02/22 Microchip sees Q2 EPS $1.42-$1.46, consensus $1.34 08/02/22 Microchip reports Q1 EPS $1.37, consensus $1.34 08/02/22 Notable companies reporting after market close 05/09/22 Microchip sees Q1 EPS $1.32-$1.36, consensus $1.28 MCHP Microchip $71.68 / +1.05 (+1.49%) 08/10/22 Chip makers now expect demand slowdown beyond PCs, WSJ reports 08/09/22 Biden signs bill giving $52.7B in subsidies to U.S. chipmakers, Reuters says 07/28/22 House passes bill giving $52B to U.S. chipmakers, Bloomberg reports 07/27/22 Senate pushes bipartisan chip bill to House to boost U.S, production, CNN says MCHP Microchip $71.68 / +1.05 (+1.49%) 06/28/22 What You Missed On Wall Street On Tuesday 06/28/22 What You Missed On Wall Street This Morning 06/28/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/28/22 Fly Intel: Pre-market Movers 11:30 Today Semiconductors 08/15/22 Microchip - MCHP 08/23/22 Microchip Technology Incorporated MCHP Microchip $71.68 / +1.05 (+1.49%) 06/29/22 Notable open interest changes for June 29th
Recommendations	Piper has 'strong conviction on pemvidutide,' still bullish on Altimmune » 11:11 08/11/22 08/11 11:11 08/11/22 11:11 ALT Altimmune $13.27 / +0.39 (+3.03%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ALT Altimmune $13.27 / +0.39 (+3.03%) 04/01/22 Altimmune initiates 48-week Phase 2 MOMENTUM trial of pemvidutide ALT Altimmune $13.27 / +0.39 (+3.03%) 08/03/22 Piper Sandler Piper says Altimmune selloff related to Novo continuing Phase 3 SELECT trial 05/17/22 Piper Sandler Altimmune price target lowered to $25 from $34 at Piper Sandler 04/28/22 Piper Sandler Lilly data does not raise bar for Altimmune, says Piper Sandler 04/12/22 B. Riley Altimmune added to '25 Picks for 22' list at B. Riley ALT Altimmune $13.27 / +0.39 (+3.03%) 07:28 Today Altimmune reports Q2 EPS (42c) vs (60c) last year 05/12/22 Altimmune reports Q1 EPS (44c), consensus (58c) 03/15/22 Altimmune reports Q4 EPS (57c), consensus (65c) ALT Altimmune $13.27 / +0.39 (+3.03%) 03/15/22 Fly Intel: Pre-market Movers 08:30 Today Altimmune - ALT
Hot Stocks	BJ's Restaurants enter partnership with DailyPay » 11:09 08/11/22 08/11 11:09 08/11/22 11:09 BJRI BJ's Restaurants $25.72 / +0.345 (+1.36%) BJ's Restaurants… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly Options BJRI BJ's Restaurants $25.72 / +0.345 (+1.36%) 07/25/22 Deutsche Bank BJ's Restaurants price target lowered to $28 from $40 at Deutsche Bank 07/22/22 Citi BJ's Restaurants price target raised to $26 from $24 at Citi 07/22/22 Piper Sandler BJ's Restaurants price target lowered to $29 from $38 at Piper Sandler 07/22/22 Barclays BJ's Restaurants price target lowered to $17 from $21 at Barclays BJRI BJ's Restaurants $25.72 / +0.345 (+1.36%) 07/21/22 BJ's Restaurants reports Q2 EPS 1c, consensus 24c 04/21/22 BJ's Restaurants reports Q1 EPS 6c, consensus (26c) 02/17/22 BJ's Restaurants reports Q4 EPS (20c), consensus (2c) BJRI BJ's Restaurants $25.72 / +0.345 (+1.36%) 07/21/22 Fly Intel: After-Hours Movers 04/21/22 Fly Intel: After-Hours Movers 04/12/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations BJRI BJ's Restaurants $25.72 / +0.345 (+1.36%) 04/21/22 BJs options imply 8.3% move in share price post-earnings
Periodicals	Walgreens offering bonuses up to $75,000 to hire pharmacists, WSJ says » 11:08 08/11/22 08/11 11:08 08/11/22 11:08 WBA Walgreens Boots Alliance $40.53 / +0.62 (+1.55%) Walgreens Boots Alliance… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options WBA Walgreens Boots Alliance $40.53 / +0.62 (+1.55%) 07/13/22 Walgreens Boots Alliance raises quarterly dividend 0.5% to 48c per share 06/28/22 NeuroMetrix appoints Fluegel to board of directors 06/28/22 Walgreens Boots Alliance ends strategic review, to keep ownership of Boots unit 06/28/22 Walgreens Boots Alliance to retain ownership of Boots business, ends review WBA Walgreens Boots Alliance $40.53 / +0.62 (+1.55%) 07/11/22 Evercore ISI Evercore cuts AmerisourceBergen to In Line on valuation, Walgreens overhang 07/08/22 JPMorgan Walgreens Boots Alliance price target lowered to $45 from $52 at JPMorgan 07/05/22 Stifel Stifel says 'logical to assume' Walgreens could look at 1Life Healthcare 07/05/22 RBC Capital Walgreens Boots Alliance price target lowered to $42 from $46 at RBC Capital WBA Walgreens Boots Alliance $40.53 / +0.62 (+1.55%) 06/30/22 Walgreens Boots Alliance backs FY22 EPS outlook of low single digit growth 06/30/22 Walgreens Boots Alliance reports Q3 adjusted EPS 96c, consensus 92c 06/29/22 Notable companies reporting before tomorrow's open 06/29/22 Notable companies reporting before tomorrow's open WBA Walgreens Boots Alliance $40.53 / +0.62 (+1.55%) 06/26/22 Reliance in talks to raise up to $8B for Boots, Mint reports 06/24/22 Walgreens settles class-action lawsuit for $105M, Reuters reports 06/22/22 Four banks lined up to fund Apollo-Reliance bid for Boots, Sky News says 05/26/22 Issa, TDR said to consider dropping out of bidding for Boots, Bloomberg reports WBA Walgreens Boots Alliance $40.53 / +0.62 (+1.55%) 06/30/22 What You Missed On Wall Street On Thursday 06/30/22 What You Missed On Wall Street This Morning 06/30/22 Fly Intel: Pre-market Movers 06/28/22 What You Missed On Wall Street On Tuesday 09/19/22 Groceryshop WBA Walgreens Boots Alliance $40.53 / +0.62 (+1.55%) 07/22/22 Unusually active option classes on open July 22nd 06/17/22 Unusually active option classes on open June 17th 05/18/22 Unusually active option classes on open May 18th 04/26/22 Walgreen Boots call volume above normal and directionally bullish
Options	Pfizer call volume above normal and directionally bullish » 11:05 08/11/22 08/11 11:05 08/11/22 11:05 PFE Pfizer $48.72 / -1.21 (-2.42%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PFE Pfizer $48.72 / -1.21 (-2.42%) 08/08/22 Pfizer, Valneva initiate Phase 3 study of Lyme disease vaccine candidate VLA15 08/08/22 Pfizer to acquire Global Blood Therapeutics for $68.50 per share in cash 08/08/22 Pfizer to acquire Global Blood Therapeutics for $68.50 per share in cash 08/07/22 Myovant Sciences, Pfizer receive FDA approval of MYFEMBREE PFE Pfizer $48.72 / -1.21 (-2.42%) 08:34 Today Deutsche Bank Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank 08/09/22 Wells Fargo Global Blood Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo 08/08/22 Cantor Fitzgerald Global Blood downgraded to Neutral from Overweight at Cantor Fitzgerald 08/08/22 Oppenheimer Global Blood Therapeutics downgraded to Perform from Outperform at Oppenheimer PFE Pfizer $48.72 / -1.21 (-2.42%) 07/28/22 Pfizer raises FY22 adjusted EPS view to $6.30-$6.45 from $6.25-$6.45 07/28/22 Pfizer reports Q2 adjusted EPS $2.04, consensus $1.80 07/27/22 Notable companies reporting before tomorrow's open 07/27/22 Notable companies reporting before tomorrow's open PFE Pfizer $48.72 / -1.21 (-2.42%) 08/05/22 Pfizer in advanced talks to buy Global Blood for about $5B, WSJ reports 08/05/22 Pfizer in talks to buy Global Blood Therapeutics for about $5B, WSJ says 07/18/22 GSK CEO says split will help deal with 'perennial underperformance,' FT reports 06/28/22 FDA panel recommends omicron update for COVID vaccine boosters, CNBC says PFE Pfizer $48.72 / -1.21 (-2.42%) 08/08/22 What You Missed On Wall Street On Monday 08/08/22 What You Missed On Wall Street This Morning 08/08/22 Fly Intel: Pre-market Movers 08/05/22 What You Missed On Wall Street On Friday 09/10/22 ESMO Congress 2022 PFE Pfizer $48.72 / -1.21 (-2.42%) 07/28/22 Unusually active option classes on open July 28th 06/30/22 Early notable gainers among liquid option names on June 30th 05/20/22 Early notable gainers among liquid option names on May 20th 04/26/22 Unusually active option classes on open April 26th

General news	Treasury Action: yields are well off of early lows » 11:05 08/11/22 08/11 11:05 08/11/22 11:05 $ECON Economic Data / + Treasury Action: yields… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 02/11/22 Gundlach sees five interest rate raises in 2022 $ECON Economic Data / + 07/26/22 Ackman says biggest risk to economy is inflation, not higher rates 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports $ECON Economic Data / + 07/27/22 What You Missed On Wall Street On Wednesday 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed On Wall Street On Wednesday
Recommendations	iStar tax-free combination to internalize Safehold management team, says Truist » 11:03 08/11/22 08/11 11:03 08/11/22 11:03 SAFE Safehold $42.97 / -0.47 (-1.08%) , STAR iStar $15.30 / -1.785 (-10.45%) Commenting on Safehold… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly SAFE STAR SAFE Safehold $42.97 / -0.47 (-1.08%) 06:38 Today Safehold, iStar enter strategic combination 07/20/22 Safehold closes transaction with Avanti Residential and $62.5M ground lease 06/15/22 Safehold increases quarterly stock dividend 4.12% to 17.7c per share 02/15/22 Safehold executes private sale of Caret Units at a valuation of $1.75B STAR iStar $15.30 / -1.785 (-10.45%) 06:38 Today Safehold, iStar enter strategic combination SAFE STAR SAFE Safehold $42.97 / -0.47 (-1.08%) 07/15/22 Morgan Stanley Safehold price target lowered to $85 from $100 at Morgan Stanley 06/28/22 B. Riley B. Riley says buy iStar into expected merger with Safehold 05/24/22 Raymond James iStar price target lowered to $21 from $33 at Raymond James 05/18/22 JPMorgan Safehold price target lowered to $52 from $66 at JPMorgan STAR iStar $15.30 / -1.785 (-10.45%) 06/28/22 B. Riley B. Riley says buy iStar into expected merger with Safehold 05/24/22 Raymond James iStar price target lowered to $21 from $33 at Raymond James 01/03/22 B. Riley iStar, Aspen Aerogels among B. Riley's top 25 stock picks for 2022 09/10/21 Fly Intel: Top five analyst initiations SAFE STAR SAFE Safehold $42.97 / -0.47 (-1.08%) 08/03/22 Safehold reports Q2 EPS 37c, consensus 40c 04/21/22 Safehold reports Q1 EPS 43c, consensus 42c 02/15/22 Safehold reports Q3 EPS 38c, consensus 41c STAR iStar $15.30 / -1.785 (-10.45%) 08/04/22 iStar reports Q2 adjusted EPS (42c), consensus (61c) 02/24/22 iStar reports Q4 adjusted EPS 87c, consensus (21c) 03 Mar 23 Sep STAR STAR iStar $15.30 / -1.785 (-10.45%) 04/23/22 Short Report: Stitch Fix bears gnawing on shares
Conference/Events	Bernstein payments/IT services analyst holds analyst/industry conference call » 11:02 08/11/22 08/11 11:02 08/11/22 11:02 Payments/IT Services… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Hot Stocks	PNC Bank eliminates non-sufficient fund fees for consumer banking customers » 10:57 08/11/22 08/11 10:57 08/11/22 10:57 PNC PNC Financial $171.67 / +2.49 (+1.47%) PNC Bank announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PNC PNC Financial $171.67 / +2.49 (+1.47%) 07/27/22 PNC Financial raises prime lending rate to 5.50%, effective July 28 07/15/22 PNC Financial says very asset sensitive 06/27/22 PNC Financial announces CCAR results 06/23/22 PNC Financial releases results of Dodd-Frank stress tests PNC PNC Financial $171.67 / +2.49 (+1.47%) 07/18/22 Morgan Stanley PNC Financial price target raised to $180 from $168 at Morgan Stanley 07/17/22 Barclays PNC Financial price target lowered to $222 from $250 at Barclays 07/12/22 Citi PNC Financial price target lowered to $170 from $190 at Citi 07/12/22 Citi Citi places 'negative catalyst watches' on KeyCorp, PNC PNC PNC Financial $171.67 / +2.49 (+1.47%) 07/15/22 PNC Financial backs FY22 revenue view up 9%-11%, consensus $20.95B 07/15/22 PNC Financial sees Q3 revenue up 4%-6% vs. Q2, consensus $5.5B 07/15/22 PNC Financial reports Q2 EPS $3.42 vs. $3.29 last year 07/14/22 Notable companies reporting before tomorrow's open PNC PNC Financial $171.67 / +2.49 (+1.47%) 07/20/22 CFPB to prod banks to cover more payment services scams, WSJ reports PNC PNC Financial $171.67 / +2.49 (+1.47%) 07/15/22 What You Missed On Wall Street On Friday 07/15/22 What You Missed On Wall Street This Morning 07/15/22 Fly Intel: Pre-market Movers 04/14/22 Fly Intel: Pre-market Movers 10/14/22 PNC Financial - PNC PNC PNC Financial $171.67 / +2.49 (+1.47%) 08/01/22 PNC Financial put volume heavy and directionally bearish
General news	European Fixed Income Summary: » 10:55 08/11/22 08/11 10:55 08/11/22 10:55 $ECON Economic Data / + European Fixed Income… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 02/11/22 Gundlach sees five interest rate raises in 2022 $ECON Economic Data / + 07/26/22 Ackman says biggest risk to economy is inflation, not higher rates 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports $ECON Economic Data / + 07/27/22 What You Missed On Wall Street On Wednesday 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed On Wall Street On Wednesday

Events

Earnings calls, analyst events, roadshows and more

Today at 11:30

4-Week Bill Auction Government Event
Today at 11:30

8-Week Bill Auction Government Event
RCMT
Today at 11:30

RCM Technologies - RCMT Conference Calls
MCHP
Today at 11:30

Semiconductors Industry Meetings
Today at 11:30

Retail & Consumer Goods Industry Meetings
CCAP
Today at 12:00

Crescent BDC - CCAP Conference Calls
FSM
Today at 12:00

Fortuna Silver Mines - FSM Conference Calls
MNTS
Today at 12:00

Momentus - MNTS Conference Calls
WDAY
Today at 12:00

Technology/Software Industry Meetings
EHC
Today at 12:30

Encompass Health - EHC Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	AYTU X AYTU Aytu BioPharma Spot Secondary Managers: Cantor Fitzgerald & Canaccord Priced at: $0.43 21.5M Shares BRBR X BRBR BellRing Brands Spot Secondary Managers: JPMorgan, Barclays, Citi, Goldman Sachs & Morgan Stanley Priced at: $23.50 14.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MDNA X MDNA Medicenna Therapeutics Spot Secondary Managers: Guggenheim, Bloom Burton Securities Priced at: $1.50 13.333M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NUZE X NUZE NuZee Spot Secondary Managers: Maxim Priced at: $0.82 4.2M Shares PFLT X PFLT PennantPark Floating Rate Spot Secondary Managers: Morgan Stanley, Goldman Sachs, JPMorgan, Keefe Bruyette, RBC Capital & Truist Priced at: $12.40 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan, Jefferies Priced at: $215.00 3.49M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MIRM X MIRM Mirum Pharmaceuticals Spot Secondary Managers: JPMorgan, SVB Securities & Evercore ISI, Raymond James Priced at: $23.00 3.48M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TDW X TDW Tidewater Spot Secondary Managers: Morgan Stanley Priced at: $17.85 3.52M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	ATNX X ATNX Athenex Secondary Managers: SVB Securities Priced at: $.75 35.3M Shares CINC X CINC CinCor Pharma Secondary Managers: Goldman Sachs, Morgan Stanley, Jefferies & Piper Sandler Priced at: $30.00 7.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EVTC X EVTC Evertec Secondary Managers: JPMorgan Priced at: $32.00 6.26M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LXU X LXU LSB Industries Secondary Managers: Goldman Sachs & UBS, Deutsche Bank, Jefferies, Piper Sandler, RBC Capital, BNP Paribas, Stifel Priced at: $13.00 13.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SOVO X SOVO Sovos Brands Secondary Managers: JPMorgan & Goldman Sachs, BofA, Credit Suisse, Barclays, UBS, Cowen, Piper Sandler, Stifel, William Blair, Telsey Advisory, Drexel Hamilton, Loop Capital Priced at: $14.00 8.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRNA X VRNA Verona Pharma Secondary Managers: Jefferies, Piper Sandler & Truist Priced at: $10.50 12.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNL X BNL Broadstone Net Lease Spot Secondary Managers: Goldman Sachs, BMO Capital, JPMorgan & Truist Priced at: $21.35 13M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KIDS X KIDS OrthoPediatrics Spot Secondary Managers: Piper Sandler & Stifel Priced at: $55.00 750K Shares MAIN X MAIN Main Street Spot Secondary Managers: RBC Capital, UBS & Wells Fargo Priced at: $42.85 1.17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	TGL X TGL Treasure Global IPO Managers: EF Hutton Priced at: $4.00 2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	BIAF X BIAF Bioaffinity Technologies IPO Managers: WallachBeth $6.00-6.25 1.285M Shares
Wed	No deals
Thurs	FRZA X FRZA Forza X1 IPO Managers: ThinkEquity $5.00 3M Shares CERE X CERE Cerevel Therapeutics Secondary Managers: Morgan Stanley, Goldman Sachs, Jefferies & Evercore ISI, Loop Capital, Seibert Williams $41.42 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PTLO X PTLO Portillo's Secondary Managers: Jefferies & Morgan Stanley, BofA, Piper Sandler $28.44 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RANI X RANI Rani Therapeutics Secondary Managers: BofA, Cantor Fitzgerald & UBS, BTIG, H.C. Wainwright $11.11
Fri	No deals

View All Syndicate Announcements »

Cantor Fitzgerald biotech/pharma analysts hold analyst/industry conference call

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access